• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of aapsjspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS J. Sep 2006; 8(3): E515–E520.
Published online Aug 18, 2006. doi:  10.1208/aapsj080361
PMCID: PMC2761059

Searching for polymorphisms that affect gene expression and mRNA processing: Example ABCB1 (MDR1)

Abstract

Cis-acting genetic variations can affect the amount and structure of mRNA/protein. Genomic surveys indicate that polymorphisms affecting transcription and mRNA processing, including splicing and turnover, may account for main share of genetic factors in human phenotypic variability; however, most of these polymorphisms remain yet to be discovered. We use allelic expression imbalance (AEI) as a quantitative phenotype in the search for functionalcis-acting polymorphisms in many genes includingABCB1 (multidrug resistance 1 gene, MDR1, Pgp). Previous studies have shown that ABCB1 activity correlates with a synonymous polymorphism. C3435T; however, the functional polymorphism and molecular mechanisms underlying this clinical association remained unknown. Analysis of allele-specific expression in liver autopsy samples and in vitro expression experiments showed that C3435T represents a main functional polymorphism, accounting for 1.5-to 2-fold changes in mRNA levels. The mechanism appears to involve increased mRNA turnover, probably as a result of different folding structures calculated for mRNA with the Mfold program. Other examples of the successful application of AEI analysis for studying functional polymorphism include5-HTT (serotonin transporter, SLC6A4) andOPRM1 (μ opioid receptor). AEI is therefore a powerful approach for detectingcis-acting polymorphisms affecting gene expression and mRNA processing.

Keywords: ABCB1, allele-specific expression, mRNA stability, cis-acting polymorphism

Full Text

The Full Text of this article is available as a PDF (449K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Johnson AD, Wang D, Sadee W. Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. Pharmacol Ther. 2005;106:19–38. doi: 10.1016/j.pharmthera.2004.11.001. [PubMed] [Cross Ref]
2. Levine M. How insects lose their limbs. Nature. 2002;415:848–849. doi: 10.1038/415848a. [PubMed] [Cross Ref]
3. Bray NJ, Buckland PR, Owen MJ, O’Donovan MC. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet. 2003;113:149–153. [PubMed]
4. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW. Allelic variation in human gene expression. Science. 2002;297:1143–1143. doi: 10.1126/science.1072545. [PubMed] [Cross Ref]
5. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics. 2005;15:693–704. doi: 10.1097/01.fpc.0000178311.02878.83. [PubMed] [Cross Ref]
6. Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem. 2005;280:32618–32624. doi: 10.1074/jbc.M504942200. [PubMed] [Cross Ref]
7. Schwab M, Eichelbaum M, Fromm MF. Genetic polymorphisms of the human MDR1 drug transporter. Annu Rev Pharmacol Toxicol. 2003;43:285–307. doi: 10.1146/annurev.pharmtox.43.100901.140233. [PubMed] [Cross Ref]
8. Lepper ER, Nooter K, Verweij J, Acharya MR, Figg WD, Sparreboom A. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2. Pharmacogenomics. 2005;6:115–138. doi: 10.1517/14622416.6.2.115. [PubMed] [Cross Ref]
9. Pauli-Magnus C, Kroetz DL. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1) Pharm Res. 2004;21:904–913. doi: 10.1023/B:PHAM.0000029276.21063.0b. [PubMed] [Cross Ref]
10. Duan J, Wainwright MS, Comeron JM, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet. 2003;12:205–216. doi: 10.1093/hmg/ddg055. [PubMed] [Cross Ref]
11. Bond C, LaForge KS, Tian M, et al. Single-nucleotide polymorphisms in the human mu opioid receptor gene alters betaendorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA. 1998;95:9608–9613. doi: 10.1073/pnas.95.16.9608. [PMC free article] [PubMed] [Cross Ref]
12. Beyer A, Koch T, Schroder H, Schulz S, Hollt V. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem. 2004;89:553–560. doi: 10.1111/j.1471-4159.2004.02340.x. [PubMed] [Cross Ref]
13. Lim JE, Papp A, Pinsonneault J, Sadee W, Saffen D. Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Mol Psychiatry. 2006;11:649–662. doi: 10.1038/sj.mp.4001797. [PubMed] [Cross Ref]
14. Wang D, Papp AC, Binkley PF, Johnson JA, Sadee W. Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit IC in human heart tissues.Pharmacogenet Genom. 2006; In press. [PMC free article] [PubMed]
15. Grewal SI, Moazed D. Heterochromatin and epigenetic control of gene expression. Science. 2003;301:798–802. doi: 10.1126/science.1086887. [PubMed] [Cross Ref]
16. Pinsonneault JK, Papp AC, Sadee W. A Helic mRNA expression of x-linked monamine oxidase a (MAOA) in human brain: dissection of epigenetics and genetic factors.Hum Mol Genet. 2006; In press. [PubMed]

Articles from The AAPS Journal are provided here courtesy of American Association of Pharmaceutical Scientists

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...